The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemiaDaniel A. Arber, James W. Vardiman|Blood|2016Cited by 10.2k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W. Vardiman, Clara D. Bloomfield, Jüergen Thiele et al.|Blood|2009Cited by 4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic dataDaniel A. Arber, Michael R. Savona, Hervé Dombret et al.|Blood|2022Cited by 2.7k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in OncologyMargaret O’Donnell, Ndiya Ogba, Martin S. Tallman et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 655
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatmentRavi Bhatia, Stephen J. Forman, Melissa Holtz et al.|Blood|2003Cited by 541